Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
- PMID: 25728065
- DOI: 10.1016/j.biotechadv.2015.02.010
Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
Erratum in
- Biotechnol Adv. 2016 Jan-Feb;34(1):64
Abstract
Diabetes mellitus is a high prevalence and one of the most severe and lethal diseases in the world. Insulin is commonly used to treat diabetes in order to give patients a better life condition. However, due to bioavailability problems, the most common route of insulin administration is the subcutaneous route, which may present patients compliance problems to treatment. The oral administration is thus considered the most convenient alternative to deliver insulin, but it faces important challenges. The low stability of insulin in the gastrointestinal tract and low intestinal permeation, are problems to overcome. Therefore, the encapsulation of insulin into polymer-based nanoparticles is presented as a good strategy to improve insulin oral bioavailability. In the last years, different strategies and polymers have been used to encapsulate insulin and deliver it orally. Polymers with distinct properties from natural or synthetic sources have been used to achieve this aim, and among them may be found chitosan, dextran, alginate, poly(γ-glutamic acid), hyaluronic acid, poly(lactic acid), poly(lactide-co-glycolic acid), polycaprolactone (PCL), acrylic polymers and polyallylamine. Promising studies have been developed and positive results were obtained, but there is not a polymeric-based nanoparticle system to deliver insulin orally available in the market yet. There is also a lack of long term toxicity studies about the safety of the developed carriers. Thus, the aims of this review are first to provide a deep understanding on the oral delivery of insulin and the possible routes for its uptake, and then to overview the evolution of this field in the last years of research of insulin-loaded polymer-based nanoparticles in the academic and industrial fields. Toxicity concerns of the discussed nanocarriers are also addressed.
Keywords: Chitosan; Diabetes; Insulin; Intestinal uptake; Oral delivery; Poly(lactic-co-glycolic acid); Polymeric nanoparticles.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.J Control Release. 2017 Oct 28;264:247-275. doi: 10.1016/j.jconrel.2017.09.003. Epub 2017 Sep 5. J Control Release. 2017. PMID: 28887133 Review.
-
Can natural polymers assist in delivering insulin orally?Int J Biol Macromol. 2017 Oct;103:889-901. doi: 10.1016/j.ijbiomac.2017.05.138. Epub 2017 May 25. Int J Biol Macromol. 2017. PMID: 28552728 Review.
-
A review of biodegradable polymeric systems for oral insulin delivery.Drug Deliv. 2016 Jul;23(6):1882-91. doi: 10.3109/10717544.2015.1052863. Epub 2015 Jun 11. Drug Deliv. 2016. PMID: 26066036
-
Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.Drug Deliv. 2014 Aug;21(5):370-8. doi: 10.3109/10717544.2014.905653. Epub 2014 May 6. Drug Deliv. 2014. PMID: 24797098
-
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.Eur J Pharm Sci. 2012 Apr 11;45(5):632-8. doi: 10.1016/j.ejps.2012.01.002. Epub 2012 Jan 10. Eur J Pharm Sci. 2012. PMID: 22248882
Cited by
-
Polylactic Glycolic Acid-Mediated Delivery of Plectasin Derivative NZ2114 in Staphylococcus epidermidis Biofilms.Antibiotics (Basel). 2024 Feb 29;13(3):228. doi: 10.3390/antibiotics13030228. Antibiotics (Basel). 2024. PMID: 38534663 Free PMC article.
-
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs.Pharmaceutics. 2024 Jan 28;16(2):183. doi: 10.3390/pharmaceutics16020183. Pharmaceutics. 2024. PMID: 38399244 Free PMC article. Review.
-
Recent advances in oral insulin delivery technologies.J Control Release. 2024 Feb;366:221-230. doi: 10.1016/j.jconrel.2023.12.045. Epub 2024 Jan 4. J Control Release. 2024. PMID: 38161033
-
Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes.Pharmaceutics. 2023 Apr 11;15(4):1215. doi: 10.3390/pharmaceutics15041215. Pharmaceutics. 2023. PMID: 37111699 Free PMC article. Review.
-
Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope?Antibiotics (Basel). 2023 Mar 28;12(4):665. doi: 10.3390/antibiotics12040665. Antibiotics (Basel). 2023. PMID: 37107027 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical